File size: 5,531 Bytes
c99c05f
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0c79542
 
 
 
 
 
 
 
 
 
 
 
 
c99c05f
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
---
license: cc-by-nc-nd-4.0
task_categories:
  - image-classification
modality:
  - image
language:
  - en
tags:
  - medical
  - ophthalmology
  - fairness
  - glaucoma
  - AMD
  - diabetic-retinopathy
  - OCT
  - fundus
pretty_name: Harvard-FairVision
size_categories:
  - 10K<n<100K
configs:
  - config_name: glaucoma
    data_files:
      - path: Glaucoma/ReadMe/data_summary_glaucoma.csv
        split: train
  - config_name: dr
    data_files:
      - path: DR/ReadMe/data_summary_dr.csv
        split: train
  - config_name: amd
    data_files:
      - path: AMD/ReadMe/data_summary_amd.csv
        split: train
---

# Dataset Card: Harvard-FairVision

## Dataset Summary

Harvard-FairVision is the **first large-scale medical fairness dataset with both 2D and 3D imaging data**, covering three major eye diseases affecting approximately 380 million people worldwide. It contains 30,000 subjects (10,000 per disease) across Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and glaucoma, each with paired SLO fundus photos and 3D OCT B-scans and six demographic identity attributes.

This dataset was introduced in the paper: [FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling](https://arxiv.org/pdf/2310.02492).

## Dataset Details

### Dataset Description

| Field           | Value |
|-----------------|-------|
| **Institution** | Department of Ophthalmology, Harvard Medical School |
| **Tasks**       | AMD detection, diabetic retinopathy detection, glaucoma detection |
| **Modalities**  | Scanning Laser Ophthalmoscopy (SLO) fundus images, 3D OCT B-scans |
| **Scale**       | 30,000 subjects (10,000 per disease) |
| **OCT size**    | 200 × 200 × 200 (glaucoma), 128 × 200 × 200 (AMD, DR) |
| **SLO size**    | 512 × 664 (folders), 200 × 200 (NPZ, normalized to [0, 255]) |
| **Total size**  | ~600 GB |
| **License**     | [CC BY-NC-ND 4.0](https://creativecommons.org/licenses/by-nc-nd/4.0/) |

- **Curated by:** Yan Luo, Muhammad Osama Khan, Yu Tian, Min Shi, Zehao Dou, Tobias Elze, Yi Fang, Mengyu Wang
- **License:** [CC BY-NC-ND 4.0](https://creativecommons.org/licenses/by-nc-nd/4.0/) — non-commercial research only
- **Paper:** [arXiv:2310.02492](https://arxiv.org/abs/2310.02492)
- **Contact:** harvardophai@gmail.com, harvardairobotics@gmail.com

### Dataset Structure

```
FairVision
├── AMD
│   ├── Training
│   ├── Validation
│   └── Test
├── data_summary_amd.csv
├── DR
│   ├── Training
│   ├── Validation
│   └── Test
├── data_summary_dr.csv
├── Glaucoma
│   ├── Training
│   ├── Validation
│   └── Test
└── data_summary_glaucoma.csv
```

Each split folder contains SLO fundus photos (`slo_xxxxx.jpg`) and NPZ files (`data_xxxxx.npz`). Per-disease metadata CSVs (`data_summary_*.csv`) provide race, gender, ethnicity, marital status, age, and preferred language for all subjects.

### Data Fields

All NPZ files share the following demographic and imaging fields:

| Field           | Description |
|-----------------|-------------|
| `slo_fundus`    | SLO fundus image, 200 × 200 (normalized) |
| `oct_bscans`    | 3D OCT B-scans (200 × 200 × 200 for glaucoma; 128 × 200 × 200 for AMD/DR) |
| `race`          | `0` = Asian, `1` = Black, `2` = White |
| `male`          | `0` = Female, `1` = Male |
| `hispanic`      | `0` = Non-Hispanic, `1` = Hispanic |
| `maritalstatus` | `0` = Married, `1` = Single, `2` = Divorced, `3` = Widowed, `4` = Legally Separated |
| `language`      | `0` = English, `1` = Spanish, `2` = Other |

Disease-specific label fields:

| Disease   | Field           | Values |
|-----------|-----------------|--------|
| Glaucoma  | `glaucoma`      | `0` = non-glaucoma, `1` = glaucoma |
| AMD       | `amd_condition` | 9-class condition string, mapped to `0` = no AMD, `1` = early dry, `2` = intermediate dry, `3` = advanced |
| DR        | `dr_subtype`    | 6-class condition string, mapped to `0` = non-vision-threatening, `1` = vision-threatening (severe NPDR or PDR) |

## Uses

### Direct Use

- Fairness benchmarking for 2D and 3D ophthalmic disease classification across race, gender, and ethnicity
- Multi-disease fairness analysis (AMD, DR, glaucoma) under a unified framework
- Development and evaluation of fairness learning methods for medical imaging
- Comparative study of 2D vs. 3D model fairness in clinical AI

### Out-of-Scope Use

Clinical decisions, patient care, or any commercial application. This dataset shall not be used for clinical decisions at any time.

## Access

The "Harvard" designation indicates the dataset originates from the Department of Ophthalmology at Harvard Medical School. It does not imply endorsement, sponsorship, or legal responsibility by Harvard University or Harvard Medical School.

## Citation

**BibTeX:**

```bibtex
@misc{luo2024fairvisionequitabledeeplearning,
  title={FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling},
  author={Yan Luo and Muhammad Osama Khan and Yu Tian and Min Shi and Zehao Dou and Tobias Elze and Yi Fang and Mengyu Wang},
  year={2024},
  eprint={2310.02492},
  archivePrefix={arXiv},
  primaryClass={cs.CV},
  url={https://arxiv.org/abs/2310.02492}
}
```

**APA:**

Luo, Y., Khan, M. O., Tian, Y., Shi, M., Dou, Z., Elze, T., Fang, Y., & Wang, M. (2024). FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling. *arXiv preprint arXiv:2310.02492*.